OrthoPediatrics (KIDS)
(Delayed Data from NSDQ)
$31.30 USD
-0.92 (-2.86%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $31.35 +0.05 (0.16%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KIDS 31.30 -0.92(-2.86%)
Will KIDS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for KIDS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KIDS
CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar?
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
KIDS: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
Other News for KIDS
Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS), Pharvaris (PHVS) and Cue Biopharma (CUE)
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
Needham medtech/diagnostic analyst holds analyst/industry conference call
Needham medtech/diagnostic analyst holds analyst/industry conference call
Needham medtech/diagnostic analyst holds analyst/industry conference call